Back to results
US 9,956,268 B2Granted
Neuropeptide Y treatment of autoimmune disease
OwnerStaley A. Brodinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for treating or delaying the onset of an autoimmune condition in a human subject comprising orally administering to the subject at an effective dose of neuropeptide Y.
Claims12
A method for decreasing levels of IL-1β, IL-2, IL-12p70, IL-13, IL-12, IL-17 (Teff), TNF-α and IFN-γ and increasing levels of IL-4, IL-10 and IL-13 in a subject, comprising the step of:
- orally administering to the subject an effective dose of neuropeptide Y.
Dependencies are inferred from the claim text.